As a specialist pharmaceutical consulting firm, Grove facilitates drug registration processes, provides ongoing support with maintenance of marketing authorisations and lifecycle management for medicines and medical devices in Central and Eastern Europe.
Through our work we are continuingly involved with the most dynamic areas at all levels of within the CEE pharmaceutical market and supply chain – in both a consulting and execution capacity. Not only are we completely aware of the issues and concerns related to entering the individual CEE countries, but we are fully appreciative of the many forces for change which impact the drug and medicinal product industry development in the region. Employing a results-oriented approach at all times, Grove assists its clients with the development and implementation of pharmaceutical marketing strategies.
It has been proven many times over that the ability to look forward underpins successful distribution, sales and marketing strategies, and nowhere is this more true than in dynamically evolving countries in Eastern Europe alongside emerging markets of Kazakhstan, Armenia, Georgia and Balkan states. Our consulting work in the region tends to revolve around opportunity identification, strategy appraisal and facilitation with the strategy execution where drug registration is a first step in a coherent market access business plan.
We are firmly established as a specialised provider of pharmaceutical consulting services in the CEE region – with our clients ranging from small and medium size dynamic concerns to the large multi-national pharma and medical device corporations.